Human height is associated with risk of multiple diseases and is profoundly determined by an individual's genetic makeup and shows a high degree of ethnic heterogeneity. Large-scale genome-wide association (GWA) analyses of adult height in Europeans have identified nearly 180 genetic loci. A recent study showed high replicability of results from Europeans-based GWA studies in Asians; however, population-specific loci may exist due to distinct linkage disequilibrium patterns. We carried out a GWA metaanalysis in 93 926 individuals from East Asia. We identified 98 loci, including 17 novel and 81 previously reported loci, associated with height at P < 5 × 10 −8 , together explaining 8.89% of phenotypic variance. Among the newly identified variants, 10 are commonly distributed (minor allele frequency, MAF > 5%) in Europeans, with comparable frequencies with in Asians, and 7
Introduction
Human height is a classical and highly heritable complex trait, with an estimated 80-90% of variation explained by genetic components (1, 2) . Height has been associated with risk of multiple diseases including cancer (3, 4) , stroke (5) and atrial fibrillation (6) . Compelling evidence has also indicated that heightassociated genetic variants may also predisposing to increased risk of cancer (7) . Recently, a large-scale genome-wide association (GWA) meta-analysis by the genetic investigation of anthropocentric traits (GIANT) consortium identified 180 loci associated with adult height in individuals of European ancestry (8) . However, the loci identified so far only explain a relatively small proportion of the variance (∼10%) in the trait, leaving additional genetic variations to be identified. In addition, a high degree of ethnic heterogeneity in adult height clearly exists. A recent study indicates population-specific loci may exist due to distinct linkage disequilibrium patterns between Europeans and East Asians, despite high trans-ethnic replicability of GWA associations (9) . Several previous GWA studies (GWAS) on adult height in Korean, Japanese and Chinese (10) (11) (12) were severely limited by their relatively small size, and therefore offer an incomplete picture of the genetic architecture of adult height in Asians.
To explore the population-specific genetic architecture of adult height, we performed thus far the largest GWAS metaanalysis in Asians. The current two-stage study included a total of 93 926 adults from seven countries/regions of East Asia. We reported here the identification of in total of 98 loci, including 17 novel and 81 previously reported loci, which associated with adult height in Asians at genome-wide significant level.
Results
In Stage 1, we performed a meta-analysis of GWA data from 11 studies, comprising 36 227 individuals. The genotyping data included ∼2.7 million genotyped or imputed single-nucleotide polymorphisms (SNPs) present in the HapMap Phase 2 http:// hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2010-05_phaseIII/ hapmap_format/consensus/ Chinese and Japanese reference panel. The Stage 1 analysis validated 32 previously reported loci (10) (11) (12) at a genome-wide significance level (Supplementary Material, Table S1 ; P < 5 × 10 −8 ). To identify additional novel loci robustly associated with adult height, we carried forward at least one SNP from each of the loci (a locus is defined as a chromosomal region at which adjacent pairs of SNPs were <1 Mb) reaching P < 1.0 × 10 −5 in Stage 1, with a total number of SNPs of 1783, into additional samples of 57 699 East Asians with GWA data available (Stage 2). We also carried forward an additional 379 previously reported SNPs (10-12) associated with height but did not reach P < 1.0 × 10 −5 in our Stage 1 data. Following the same analysis strategy as in Stage 1, each individual study in Stage 2 tested the association of adult height with each SNP, and meta-analyses using the inverse variance weight method were performed to combine the individual study statistics of Stage 2, and then of both Stage 1 and Stage 2 using a fixed-effect model ( Supplementary Material, Fig. S1 ).
In the combined analysis of Stages 1 and 2, we identified 17 novel loci located on 11 autosomal chromosomes ( Fig. 1 ) at or near genes including PTPN14, CRIM1, ZNF638, SLC17A2, UBD, HCG22, EXTL3, MYC, FADS1, CCND1, PAN2, PTPN9, CDK10, KDM6B, ILF3, DNM2 and RBL1 associated with height at a genomewide significance level (Table 1 ; Supplementary Material, Fig. S2 ; P = 2.24 × 10 −8 -6.80 × 10 −35 ). These loci each explained 0.02-0.19% of the variance of height. We also found five novel loci showing nearly genome-wide significant associations (P = 1.76 × 10 −7 -6.00 × 10 −8 ; Supplementary Material, Table S2 ). Supplementary Material, Table S9 presents detailed information for the nearest genes near the 17 newly identified height loci.
In addition, 81 previously reported height-associated SNPs (10-12) showed genome-wide significant associations (P < 5 × 10 −8 ; Supplementary Material, Table S1) in the combined analysis of Stages 1 and 2. Furthermore, 13 previously reported loci reached nearly genome-wide significance (P < 5 × 10 −7 ; Supplementary Material, Table S1 ) and 62 loci showed a nominally significant association (5 × 10 −7 < P < 0.05; Supplementary Material, Table S3 ) in the combined analysis. There were 17, 105 and 5 previously reported height-related variants among Asian, European and African, respectively, failed to be replicated in the present study.
Using the largest of our study samples (SGWAS; N = 9297; Supplementary Material, Methods), we found that the 17 newly identified loci explained 2.33% of the phenotypic variance in height; in total, the 98 genome-wide significant loci explained 8.89% of the phenotypic variance, these might be an overestimate due to winner's curse. When we removed these 98 height variants and nearby correlated SNPs from the meta-analysis, the QQ plot indicated that the number of low P-values still deviated from the expectation (Supplementary Material, Fig. S3 ).
We further compared the frequencies of the index SNPs representing 17 newly identified loci between East Asians and Europeans (HapMap CEU frequencies, http://www.broadinstitute. org/collaboration/giant/index.php/GIANT_consortium_data_files). Seven SNPs are with minor allele frequency (MAF) <5% in Europeans. Ten of the 17 newly identified SNPs are commonly distributed (MAF > 5%) in Europeans, showing similar frequencies as in Asians (Fig. 2 ). We noted that 6 of these 10 SNPs showed nominally significant associations with height in GIANT, although none reached genome-wide significance level.
For the newly identified loci, we also analyzed the top SNPs of each locus (discovery stage P < 1.0 × 10 −5 ), conditioning on the index SNP, in the combined samples using GCTA software (13) . At a genome-wide significance level, we identified a second independent association for SNP rs10172196 near CRIM1 (P = 3.97 × 10 −9 ; r 2 = 0.04 with the index SNP rs3755206) and rs12624 near HCG22 (P = 1.01 × 10 −8 ; r 2 = 0.01 with the index SNP rs2251830). In accordance with previous studies (13) , we defined a locus as a chromosomal region at which adjacent pairs of SNPs were <1 Mb. Our observations are in line with a previous analysis in GIANT which found multiple independent-associated SNPs of a single locus for height (13) . For each locus, the nearest gene to the strongest associated variant was prioritized as biological candidates.
We further evaluated the heterogeneity of the 98 identified loci across studies, countries/regions, and between genders within our East Asian samples. The P-value of <0.05 was considered nominally significant. Among these loci, only three showed significant heterogeneity across studies (P = 0.006-0.03; I 2 = 79.4-86.8%) and four showed nominally significant heterogeneity across countries/ regions (P = 0.003-0.015; I 2 = 67. 4 Table S5 and S6). Our data indicate that the vast majority of the genetic variants identified in our study have consistent effects on height across various populations in Asia. In addition, 15 loci displayed nominally significant sexual dimorphism in association with height (P < 0.001-0.048; I 2 = 74.3-97.5%; Supplementary Material, Table S7 ). However, none of the above heterogeneity tests remained significant after controlling for multiple comparisons.
To explore biological connections between the 98 height loci which reached GWAS significance in East Asians, we performed a pathway analysis based on the Stage 1 meta-analysis results using the meta-analysis gene-set enrichment of variant associations (MAGENTA) method (14, 15) . Our analysis revealed seven biological pathways and six molecular functions nominally enriched (P < 0.05), many of which lie within the validated height loci (Supplementary Material, Table S10 ). Among them, the histone gene set remained significant after controlling for multiple testing. We also applied the GRAIL text-mining algorithm to explore non-random and literature-based connectivity among the genes (Supplementary Material, Fig. S5 ). Among the genes implicated by proximity to the height-associated loci identified in the present study, 98 genes were identified as significant (P < 0.01), all obtaining false discovery rate (FDR) < 0.05. Forty SNPs reached GRAIL P-value < 0.01 and FDR < 0.05, indicating that the 40 regions tagged by these SNPs contained genes which were related to other implicated genes more than expected by chance (Supplementary Material, Table S11 ). Totally, GRAIL identified strong connections between members of three key biological pathways: insulin/insulin-like growth factor 1 (IGF1) pathway (encoded by GH1, IGF1 and IGF1R), the Hedgehog signaling pathway (encoded by IHH and HHIP) and the transforming growth factor (TGF)-β signaling pathway (encoded by LTBP1, TGFβ and BMP6). Among them, two biological pathways of the insulin/IGF1 pathway and the Hedgehog signaling pathway were consistent with the results in the MAGENTA pathway analysis. The Hedgehog signaling pathway and the TGFβ signaling pathway were reported in the GIANT study (8) .
Discussion
In thus far the largest GWA meta-analysis of height in Asians, we identified 98 loci (MAF ranges from 0.08 to 0.49), including 17 novel and 81 previously reported loci. These variants together explained ∼8.89% of the phenotypic variation in height in East Asians. Our findings considerably expand knowledge of the genetic architecture of human height in Asians.
For the 17 novel height loci in Asians, 7 newly identified SNPs are with low frequency (MAF < 5%) in Europeans. Marigorta et al. observed that GWAS with larger sample sizes might be more powerful in detection of variants with weaker effects than with lower frequencies (9) . This may partly explain why these seven SNPs were not detected in GIANT and highlight the importance of GWAS in various ethnic populations in identifying novel genetic variants. We have compared the associations of the 17 loci with height between our study and GIANT; and found that the effect sizes of the common SNPs observed in GIANT were consistently smaller than those in the present study (Supplementary Material, Table S12 ).
Except for the 17 novel loci for height in Asians, we replicated 81 previously reported loci, mostly identified in European populations. In addition, 75 reported loci showed nominally significant association with height in the present study. These observations are in line with recent findings of high trans-ethnic replicability of GWA associations between Europeans and East Asians (9) , and lend further support to the hypothesis that these two ethnic populations may share causal variants for numerous loci determining phenotypes such as adult height. Of note, six confirmed loci including ATP13A2, NUDT3, ATF7, ATP5G2, NUP37 and IGF1 were only identified in Asian population. For example, rs7313075 at IGF1, a gene known to be involved in skeletal development (16, 17) , was reported in previous GWAS in Asians (11) and showed a robust association with adult height in the present study (P = 4.00 × 10 −47 ), but was not reported in the GIANT consortium. The index SNP is less common in Europeans (effect allele frequency, EAF = 0.10) (18) than in East Asians (EAF = 0.32), although GIANT would have >80% power to detect similarly sized genetic effect with sample size of >130 thousands subjects. Some other previously reported loci from GWAS in Europeans or Asians failed to be validated in the present study (Supplementary Material, Tables S3 and S4), probably due to sampling error or insufficient power of the current analysis.
Among the 17 novel loci, 2 loci (PTPN14 at 1q32.2 and PTPN9 at 15q24.2) belong to the same protein tyrosine phosphatase (PTP) family. The PTPN9 locus has been suggestively associated with adult height in Japanese (11) . In addition, another PTP family member PTPN11 (12q24.1) was previously associated with Noonan syndrome (19), a Mendelian disorder characterized by proportionately short stature and other symptoms such as dysmorphic facial features, heart disease (20) and acute myeloid leukemia (21) .
In addition, several newly identified loci might have pleiotropic effects. For example, the newly identified SNP rs174547 in FADS1-FADS2 gene cluster, a member of the fatty acid desaturase (FADS) gene family involved in the metabolism of polyunsaturated fatty acids, shows a perfect correlation (r 2 = 1.0; Fig. 3 ) with SNPs associated with phospholipid levels (22, 23) , carotid intima media thickness (24) , lipid metabolism (25, 26) , liver enzyme levels (27) and coronary heart disease (25) . The index SNPs of seven other newly identified loci also strongly correlate with SNPs associated with various traits such as circulating metabolites, cardiovascular disease and certain cancers (Supplementary Material, Table S8 ). Our observations suggest that these genes may code for products involved in biological function on various targets.
Our pathway analyses found that seven important pathways and six molecular functions are likely to be involved in regulation of height. Among them, the Hedgehog signaling pathway, histone, transcription factor and extracellular matrix glycoprotein were found to be associated with height in previous studies (8, 28, 29) . Another six novel pathways (sulfur metabolism, glycosylphosphatidylinositol anchor biosynthesis, fructose and mannose metabolism, the insulin signaling pathway, glutamate receptor signaling and wnt signaling pathway) and three molecular functions (nuclear hormone receptor, kinase modulator and select regulatory molecule) were nominally significant (8) . Notably, the newly identified wnt signaling pathway, which includes two novel height loci (CTBP2 and MYC), has been involved in body axis specification (30) , appendicular skeletal development (31) and bone mineral density regulation (32, 33) .
In conclusion, our study identified 98 loci associated with adult height in East Asians at P < 5 × 10 −8 , including 17 novel loci. These variants together explained ∼8.89% of the phenotypic variation in height in East Asians. We have shown that the majority of loci encompassing common variants related to adult height are shared between Asians and Europeans, and we have provided evidence for novel variants related to adult height in Asians. For example, according to a new study by GIANT (34) that was published when our paper was under review, the majority of the novel loci identified in our study were also detected in the 
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Europeans, though the index variants were not identical. These observations suggest that the height-associated loci are largely shared by Asians and Europeans. Even though several loci such as EXTL3, MYC and FADS1 were not found in GIANT, suggesting that these loci are likely to affect height only in Asians. Taken together, our results offer new insight into the genetic architecture of height in Asians and suggest novel biological pathways that may determine adult height.
Materials and Methods

Study design
This study included two stages. Stage 1 was meta-analysis of study-specific results on the association between SNPs and height from 11 GWAS that participated in the consortium and included a total of 36 227 individuals of East Asian ancestry. The promising SNPs selected from the Stage 1 meta-analysis were further examined by in silico (Stage 2) replication analyses. Basic information for all the participating studies is summarized in Supplementary Material, Fig. S1 , Tables S1 and S2 and Note. Each participating study was approved by its local institutional review board, and informed consent was obtained from participants.
Stage 1 samples and genotyping
The sample sizes of the 11 GWAS in Stage 1 varied from 742 to 9297, and in total of 36 227 individuals were included. Approximately 41.3% of the participants were male, and the ages ranged from 18 to 95 years (all ≥18 years). For genotyping, four studies used commercially available Affymetrix arrays, six studies used Illumina platforms and one study of SGWAS used both platforms (detailed information is provided in the Supplementary Material, Table S3 and Note). To allow for the combination of data derived from different genotyping platforms and to improve coverage of the genome, genotype imputation was performed by each participating study using MACH http://www.sph.umich.edu/csg/ abecasis/MACH/index.html (35) , IMPUTE http://mathgen.stats. ox.ac.uk/impute/impute.html (36) or BEAGLE (37) . For each SNP, the imputation software estimates its overall imputation quality score. Study-specific details are presented in Supplementary Material, Table S3 .
Stage 1 statistical analysis
A uniform statistical analysis protocol was followed by each participating study. Each study measured height. To improve the normality of the height distribution and alleviate the impact of outliers, the age-adjusted z-score was calculated separately for height values for each gender in each study. The association between the SNPs and the z-score-transformed height values was analyzed with a linear additive regression model. Stratified analyses by gender were also performed by each study.
A total of 2 704 730 autosomal SNPs were meta-analyzed across 22 input files (many of the 11 cohorts had separate male-female files). We used a cutoff of N × MAF > 3 to exclude the extremely rare variants present in only one or two samples that might be due to genotyping/imputation errors or private mutations. We used effects weighted by the inverse variance that was implemented in the METAL software package (see http:// www.sph.umich.edu/csg/abecasis/Metal/). The meta-analyses were carried out with all data combined and were also stratified by gender. The presence of heterogeneity across studies, populations and between genders was tested with Cochran's Q statistics (38) and I 2 statistic (39) .
To correct each study for residual population stratification or cryptic relatedness, the meta-analyses were performed with genomic control correction (40) by adjusting for the study-specific inflation factor (λ), which ranged from 1.00 to 1.08 in Stage 1 (Supplementary Material, Table S3 ). After study-specific genomic control adjustment, the estimated inflation factor for the Stage 1 meta-analysis statistic was 1.112. The inflation factor for males and females was 1.051 and 1.050, respectively ( Supplementary  Material, Fig. S4 ).
On the basis of the Stage 1 meta-analysis on the association between SNPs and height in all participants, we selected for Stage 2 replication a total of 2162 SNPs, which included 1783 SNPs with P < 1.0 × 10 −5 and 379 SNPs located in previously reported height-related loci that had P > 1.0 × 10 −5 in the Stage 1 meta-analysis.
Stage 2 in silico replication
The 2162 SNPs selected for replication were investigated in an independent set of 57 699 individuals (53.0% males, 100% of the samples were ≥18 years old) of East Asian ancestry from five additional GWAS. The sample sizes of the five additional studies varied between 1881 and 43 386 subjects. The RIKEN study was the main source of the replication data and included 43 386 individuals. Three studies (SCES, CAGE and RIKEN) used the Illumina platform and two studies of HEXA and BGWAS used an Affymetrix array. Genotype imputation was also performed by each study using MACH http://www.sph.umich.edu/csg/abecasis/ MACH/index.html (35) , IMPUTE http://mathgen.stats.ox.ac.uk/ impute/impute.html (36) or BEAGLE (37) , as for studies included in Stage 1.
Each study individually conducted a similar analysis of the SNPs selected from Stage 1, using the same protocol as in Stage 1. The Stage 2 data were combined using effects weighted by the inverse variance meta-analysis methods as in Stage 1 without genomic control correction. The results from Stages 1 and 2 were combined and analyzed using meta-analysis methods. Quanto 1.2.4 was used for power calculation (http://biostats.usc.edu/ software). The genome-wide set of association results from the GWAS meta-analysis stage of the present study could be found on AGEN website, http://www.agenconsortium.org/about.php.
Quality control procedures
The following quality control procedures were recommended for each participating study. SNPs were excluded, either in the primary analysis conducted by each participating study or at the meta-analysis stage (Supplementary Material, Table S3 ), if they had (i) SNPs with a call rate <95%, (ii) P < 1.0 × 10 −4 for Hardy-Weinberg violation, (iii) SNPs with a concordance rate <95% among the duplicated QC samples, (iv) SNPs with MAF < 1%, (v) low imputation quality (for imputed SNPs; r-hat < 0.3 for MACH http://www.sph.umich.edu/csg/abecasis/MACH or proper-info <0.5 for IMPUTE http://mathgen.stats.ox.ac.uk/impute/impute. html) and (vi) samples that were potentially contaminated. Samples from individuals were removed if they had a call rate of <90%, if they showed first-degree cryptic relationships in an identity-by-descent (IBD) analysis or if they were potentially contaminated. The specific quality control procedures adopted by each study are summarized in Supplementary Material, Table S3 .
Conditional analysis
To investigate the independent association of SNPs in the same locus, the conditional and joint analyses were conducted using the combined summary estimates of 1750 SNPs in the combined two-stage analysis and a reference population (SGWAS, n = 9297) with genotyping information, using GCTA software (http://www. complextraitgenomics.com/software/gcta/) according to the corresponding instruction. Regional association plot of the 17 novel height loci were generated using the LocusZoom (http://csg.sph. umich.edu/locuszoom/) with data from the UCSC Genome Browser (http://www.genome.ucsc.edu/).
Estimation of the explained variance
The fraction of variance explained by an individual heightassociated SNP was estimated by 2β 2 f(1 − f ) (41), where f is the frequency of the variant and β is its additive effect estimated from the combined data. We subsequently estimated the overall fraction of variance that can be explained by the 17 novel loci and the total 98 loci identified in the current study, respectively, by using multiple linear regression model in 9297 participants from the largest individual sample (SGWAS) of our meta-analysis. The adjusted multiple regression Rsq is an estimate of variance explained.
MAGENTA pathway analysis
MAGENTA (15) is (GSEA)-like statistical test. By calculating a gene-set enrichment P-value and a FDR for a given biological pathway or gene set of interest, MAGENTA can evaluate prespecified gene sets for enrichment of modest associations with a complex disease or trait. This method does not require genotype data, making it relevant to our GWAS meta-analyses.
In our study, the pathway analysis was based on the data of meta-analysis results of Stage 1 studies, and we used gene-set annotations from the KEGG, PANTHER, INGENUITY and Gene Ontology databases, to find out whether our height loci belong to specific biological pathways, and potentially to discover new pathways that may be enriched for modest height associations not yet identified. KEGG, PANTHER and INGENUITY pathways were downloaded from the Molecular Signatures Database (MsigDB, http://www.broad.mit.edu/gsea/msigdb/collections. jsp), PANTHER molecular function gene sets were downloaded from the PANTHER website (http://www.pantherdb.org/) and Gene Ontology biological process and molecular function categories were downloaded from the Gene Ontology website (http:// cvsweb.geneontology.org/).
GRAIL analysis
GRAIL (42) evaluates each gene within a confirmed heightassociated locus for relatedness with all other implicated genes through text-mining in PubMed abstracts, and the degree of relatedness is assessed by text-based similarity. We conducted the unconventional model for GRAIL analysis using the hg18 build of the human genome and the December 2012 PubMed data, although bias may be generated from the identification of novel associations stimulated by GWAS. Nevertheless, the December 2012 PubMed abstracts identified 80.9% of the significant genes revealed by its 2006 equivalence. We conducted Human Molecular Genetics, 2015, Vol. 24, No. 6 | 1797 at Shanghai Information Center for Life Sciences, CAS on September 23, 2015 http://hmg.oxfordjournals.org/ simulations to 100 sets of randomly selected SNPs, each containing 89 SNPs and implicating 434 ± 22 (5%) genes. The median number of P < 0.01 hits was 6 (P < 0.001, the Wilcoxon signed rank test, power >99.9%, power calculated with GPower 3.1 (43) with a range of 0-29, suggesting that these height loci were functionally related with high confidence.
